Indaptus Therapeutics, Inc. Increase (Decrease) in Deferred Liabilities
Indaptus Therapeutics, Inc. (INDP) reported Increase (Decrease) in Deferred Liabilities of -$873.84 thousand for the 6-month period ending 2021-06-30, per its 10-Q filed 2022-08-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredLiabilities · last filed 2022-08-08
- Indaptus Therapeutics, Inc. increase (decrease) in deferred liabilities for the quarter ending 2021-06-30 was -$268.85K.
- Indaptus Therapeutics, Inc. increase (decrease) in deferred liabilities for the quarter ending 2021-03-31 was -$604.99K.
| Period end | Increase (Decrease) in Deferred Liabilities 3 month | Increase (Decrease) in Deferred Liabilities 6 month |
|---|---|---|
| 2021-06-30 | -$268.85K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$873.84K 10-Q · filed 2022-08-08 |
| 2021-03-31 | -$604.99K 10-Q · filed 2022-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |